EIF2A and pancreatic ductal adenocarcinoma: successfully demonstrated that BZW1 can promote glycolysis in pancreatic ductal adenocarcinoma by enhancing eIF2α, consistent with our single‐cell sequencing analysis showing that BZW1 affects metabolism and thus tumour growth outcomes.5, 21